Preparation of Zinc-Doped Hydroxyapatite Ceramics and Evaluation of Biocompatibility and Antibacterial Activity.
Guerra-López JR., Bianchi AE., Ramos MA., Ubertino M., Ferraresi-Curotto V., Güida JA.
Laboratory Study, published in J Funct Biomater (2025) — summary generated from the PubMed abstract.
Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.
- Level A · Stronger Clinical Evidence
- Level B · Emerging clinical evidence with positive signals
- Level C · Early human research exploring benefits
- Level D · Scientific groundwork from lab and animal studies
- Emerging · Emerging topic under active research
This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.
- Study type
- Laboratory Study
- Journal
- J Funct Biomater (2025)
- Country
- Switzerland
- Reported sample size
- —
- Source database
- PubMed
- PMID
- 40137367
- DOI
- 10.3390/jfb16030088
Abstract (original English)
Bacterial resistance and the demand for novel antibacterial strategies represent major challenges in contemporary medicine. In this study, zinc-doped hydroxyapatite (Zn-HA) samples with 3, 5, and 10 wt% Zn(II) were synthesized using wet precipitation synthesis and sintered at 700 and 800 °C. The samples were characterized by X-ray Diffraction, Fourier Transform Infrared Spectroscopy, Raman Spectroscopy, and Scanning Electron Microscopy. The antimicrobial properties of the Zn-HA were tested against four bacterial strains- Staphylococcus aureus , Enterococcus faecalis , Salmonella typhimurium , Escherichia coli -and the fungus Candida albicans. Both 5 wt% and 10 wt% Zn-HA effectively inhibited the growth of all microorganisms. Notably, 10wt% Zn-HA exhibited the best results, with inhibition rates of 50.2% against S. aureus , 36.5% against E. faecalis , 47.5% against P. aeruginosa , 31.8% against E. coli , and 24.7% against C. albicans . There were no significant differences in the growth of adipose mesenchymal stem cells between the prepared samples and the control. For osteogenic differentiation, dye uptake was 1.2 times higher for HA and 5 wt% Zn-HA, and 1.3 times higher for 3 wt% Zn-HA compared to the control. These results suggest that developed ceramics may be effective in regenerative medicine, paving the way for innovative treatments.
What this study does not prove
- • This study does not prove SVF is an approved treatment or a replacement for standard care.
- • This is preclinical work; animal or laboratory results cannot be applied to humans.
Evidence level
Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.
How we grade evidenceBrowse all related research
Filter the research library by this study's title keywords, author, or publication year.